Market Tracker

09/19 6:35pm ET

Repligen Corp (NASDAQ:RGEN)

During the Trading Day
19.71 +0.06 / +0.31%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
19.71 -0.0025 / -0.01%
 
Volume: 152.7K

Today’s Trading

Previous close19.65
Today’s open19.82
Day’s range19.50 - 20.06
Volume803,205
Average volume (3 months)391,581
Market cap$641.5M
Dividend yield--
Data as of 3:59pm ET, 09/19/2014

Growth & Valuation

Earnings growth (last year)+11.11%
Earnings growth (this year)-46.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+9.48%
P/E ratio39.4
Price/Sales6.34
Price/Book6.04

Competitors

 Today’s
change
Today’s
% change
INSMInsmed Inc+0.03+0.23%
PRTAProthena Corporation...+0.61+2.66%
RPTPRaptor Pharmaceutica...-0.33-3.06%
MGNXMacroGenics Inc-0.21-0.96%
Data as of 4:14pm ET, 09/19/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)$0.05
Annual revenue (last year)$68.2M
Annual profit (last year)$16.1M
Net profit margin23.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Chief Operating Officer
Tony J. Hunt
Corporate headquarters
Waltham, Massachusetts

Forecasts